AGP Picks
View all

Perspectify logo Perspectify News

Labels

Read articles from across the media landscape with news outlet bias labels for added context. Learn about labels.

Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Supernus and Indivior to Merge, Forming a New CNS-Focused Pharma Company

Supernus and Indivior to Merge, Forming a New CNS-Focused Pharma Company

AstraZeneca-Bristol Myers $400 Billion Merger Could Result In Biggest Pharma Company

AstraZeneca-Bristol Myers $400 Billion Merger Could Result In Biggest Pharma Company

Health Tech Promised Simplicity — Why Does It Feel Like More Work?

Health Tech Promised Simplicity — Why Does It Feel Like More Work?

Leading pharma company recalls eye drops in India after contamination scare | Full list of 10 products here

Leading pharma company recalls eye drops in India after contamination scare | Full list of 10 products here

One in 6 Deprescribed Medications Are Restarted Within 90 Days

One in 6 Deprescribed Medications Are Restarted Within 90 Days

AI to revolutionize pharma industry, says expert

AI to revolutionize pharma industry, says expert

India’s Role As ‘Pharmacy of the World’ Faces Headwinds With Trump Tariff Uncertainty

India’s Role As ‘Pharmacy of the World’ Faces Headwinds With Trump Tariff Uncertainty

FDA committee approves loosening peptide regulation despite own evidence

FDA committee approves loosening peptide regulation despite own evidence

<![CDATA[Pharmaceutical Executive Daily: Pathos AI Enters Two lIcensing Deals]]>

<![CDATA[Pharmaceutical Executive Daily: Pathos AI Enters Two lIcensing Deals]]>

<![CDATA[FDA grants tentative approval to new cabozantinib capsule formulation ]]>

<![CDATA[FDA grants tentative approval to new cabozantinib capsule formulation ]]>

Sibeprenlimab (Voyxact) Stabilizes Kidney Function in IgAN

Sibeprenlimab (Voyxact) Stabilizes Kidney Function in IgAN

Best Testosterone Support Supplements: I Tested 25 Brands

Best Testosterone Support Supplements: I Tested 25 Brands

Pregnancy- and lactation-associated osteoporosis: New statement provides practical guidance

Pregnancy- and lactation-associated osteoporosis: New statement provides practical guidance

<![CDATA[Inside Pharma's Patent Battleground: The Policy Changes Reshaping Generic and Biosimilar Competition]]>

<![CDATA[Inside Pharma's Patent Battleground: The Policy Changes Reshaping Generic and Biosimilar Competition]]>

MSD records one hit, one miss with TL1A drug tulisokibart

MSD records one hit, one miss with TL1A drug tulisokibart

Workforce Augmentation Through AI: Closing the Talent Gap Without Adding Headcount

Workforce Augmentation Through AI: Closing the Talent Gap Without Adding Headcount

Is automated quality inspection easier than you think?

Is automated quality inspection easier than you think?

The Great Casualty of COVID-19: The Healthcare Industry

The Great Casualty of COVID-19: The Healthcare Industry

Yemeni Honey: From Natural Resource to Promising Pillar for Pharmaceutical Industry

Yemeni Honey: From Natural Resource to Promising Pillar for Pharmaceutical Industry

Pfizer targets $2.5bn more in cost savings

Pfizer targets $2.5bn more in cost savings

Sign up for:

Medical Industry Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Medical Industry Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.